Pfizer Inc.
PFEPfizer Inc.
NYSE
Healthcare
Drug Manufacturers - General
$28.36
-0.18(-0.6%)
52W $21.59 – $28.55
AI-generated
Pfizer Inc.
Revenue breakdown: Product (31.3%), Excluding Comirnaty And Paxlovid (30.2%), Eliquis (4.4%).
$161.3BMkt Cap
$62.6BRev TTM
$7.8BNI TTM
19.6xP/E TTM
Latest Earnings
10-K
FY FY2025Feb 25, 202610-K for FY2025 was filed on 2026-02-26. AI summary is not available yet.
Fundamentals
How The Business Makes Money
Revenue by Segment
Product31.3%($156.9B)
Excluding Comirnaty And Paxlovid30.2%($151.5B)
Eliquis4.4%($22.1B)
Comirnaty4.2%($20.9B)
Prevnar Prevenar Family3.9%($19.4B)
Vyndaqel3%($15.2B)
Ibrance2.6%($13.2B)
Other Hospital2.5%($12.7B)
Paxlovid1.9%($9.4B)
Other Primary Care Products1.8%($8.8B)
Royalty1.4%($6.8B)
Xtandi1.2%($5.9B)
Other Specialty Care0.9%($4.4B)
Xeljanz0.8%($4.0B)
Pfizer Centre One0.7%($3.8B)
Oncology Biosimilars0.7%($3.7B)
Nurtec ODT Vydura0.7%($3.6B)
Padcev0.7%($3.6B)
Other Oncology Products0.7%($3.6B)
Inlyta0.6%($2.9B)
Abrysvo0.5%($2.7B)
Lorbrena0.5%($2.3B)
Enbrel0.4%($2.1B)
Adcetris0.4%($2.1B)
Sulperazon0.4%($2.0B)
Bosulif0.4%($1.9B)
Braftovi Mektovi0.4%($1.8B)
Zavicefta0.3%($1.7B)
Inflectra Remsima0.3%($1.6B)
Genotropin0.3%($1.5B)
Zithromax Zmax0.3%($1.3B)
Octagam0.2%($1.2B)
Aromasin0.2%($1.1B)
Tukysa0.2%($961M)
FSMEIMMUN Tico Vac0.2%($867M)
Cresemba0.2%($825M)
Orgovyx0.1%($742M)
Cibinqo0.1%($627M)
Elrexfio0.1%($447M)
Paxlovid NDA Labeled US Strategic National Stockpile0.1%($442M)
Talzenna0.1%($363M)
Tivdak0.1%($282M)
Pfizer Ignite0%($167M)
Revenue by Geography
US55.9%($103.9B)
International Developed Markets28.6%($53.2B)
International Emerging Markets15.4%($28.7B)
Analyst View
Company Profile
CIK0000078003
ISINUS7170811035
CUSIP717081103
Phone212 733 2323
Address235 East 42nd Street, New York City, NY, 10017, US
SEC EDGAR